Concepedia

Yann Abraham

YA

15

Publications

2.7K

Citations

13

H-Index

2000

Active since

Affiliations

Janssen (Belgium)(Current)

Janssen (United States)

Novartis (Switzerland)

University of Southern Denmark

Levine Cancer Institute

Yann Abraham is an author at Janssen (Belgium) specializing in medicine, natural sciences, and proteomics.

Top concepts

MedicineNatural SciencesProteomicsCell BiologyCell SignalingMolecular BiologyBiochemistryCytoskeletonTumor BiologyDrug Discovery

Publications per year

2000–2023

15

Publications

15

Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors

Marcus Bantscheff, Dirk Eberhard, Yann Abraham et al. · Nature Biotechnology · 2007 · 1K citations

Quantitative Chemical Proteomics, Biochemistry, Medicine +9

Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes

Marcus Bantscheff, Carsten Hopf, Mikhail M. Savitski et al. · Nature Biotechnology · 2011 · 661 citations

Chemoproteomics Profiling, Molecular Characterization, Drug Target +10

YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors

Patricia Marti, Claudia Stein, Tanja Blumer et al. · Hepatology · 2015 · 239 citations

High-resolution chemical dissection of a model eukaryote reveals targets, pathways and gene functions

Dominic Hoepfner, Stephen B. Helliwell, Heather Sadlish et al. · Microbiological Research · 2013 · 176 citations

Prokaryotic System, Protein Assembly, Structural Bioinformatics +11

High‐Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action

Homer Adams, Frederik Stevenaert, Jakub Krejcik et al. · Cytometry Part A · 2018 · 154 citations · Full text

Rows per page

1–5 of 15